Human Growth Hormone (HGH) produces a lot of powerful effects including an increase in muscle mass, energy, and a boost in metabolism, but it can be dangerous to introduce the hormone directly into the body. Rather than do this, a peptide such as CJC-1295 safely triggers your body to produce the hormone on its own, in a natural manner.
The research was initially carried out on the peptide because it was thought that it could treat certain diseases, but professional athletes have soon discovered its performance-enhancing effects. It has gained an appeal amongst athletes and the athletic community worldwide, helping synthesize protein and cause more muscle tissue to grow. It is also largely appealing as an anti-aging peptide, typically combined with other peptides such as Ipamorelin, although the latter has a shorter half-life, smaller period of action and there are some ipamorelin side effects.
Manufacturers first created a peptide known as Sermorelin with a half-life of 30 minutes called CJC-1295. However, this was modified in the future by adding a Drug Affinity Complex (DAC), which helps increase the overall half-life by 8 days – this is what’s known as CJC-1295 DAC. This means that CJC-1295 remains active in the body for a longer duration, leading to sustained GH release. It achieves this prolonged activity by binding to and modifying a protein called albumin, which acts as a carrier in the bloodstream, preventing its rapid breakdown.
CJC-1295 is often used in medical and research settings to study the effects of increased GH levels and explore potential therapeutic applications. It may be employed to evaluate its impact on conditions related to growth hormone deficiency, muscle wasting, age-related decline, and other disorders where GH supplementation could be beneficial.